Latest News

FDA, partnering with New York health tech firm, seeks to collect ‘real-world’ data on Covid-19

The Food and Drug Administration said Tuesday that it will launch a new research project focused on real-world evidence — data collected by insurance companies, in electronic health records, and in other places in medicine — to learn more about Covid-19, including how diagnostics and medications are being used in the pandemic and how best to design studies to test them.

The project is a collaboration with Aetion, a New York health tech startup that specializes in real-world evidence.

Read the rest…

Source link

Related posts

Yale researchers develop way to attack RNA with small-molecule drugs


New continuous glucose monitor may cut hypoglycemia in T1DM


Second HPV-related primary cancers common in survivors


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World